SCP
DXCM icon

Silverleafe Capital Partners’s DexCom DXCM Stock Holding History

Silverleafe Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-92,228
Closed -$3.44M – 79
2019
Q3 		$3.44M Buy
92,228
+79,568
+628% +$3.09M 2.27% 17
2019
Q2 		$474K Buy
+12,660
New +$398K 0.29% 43

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Silverleafe Capital Partners's DXCM Position: Q4 2019 in Review

Silverleafe Capital Partners sold out of DexCom (DXCM) in Q4 2019, closing a stake of 92,228 shares — an estimated $3.44M sold.

Silverleafe Capital Partners first reported a position in DXCM in Q2 2019 and held it in 2 quarters. The position peaked at $3.44M in Q3 2019. 509 funds tracked by Wall St. Rank hold DXCM as of Q4 2019.

  • Silverleafe Capital Partners reported no remaining DexCom position as of Q4 2019 after selling out during the quarter.
  • Silverleafe Capital Partners sold 92,228 DexCom shares in Q4 2019, an estimated $3.44M.
  • Silverleafe Capital Partners first reported a position in DexCom in Q2 2019 and held it in 2 quarters.
  • Silverleafe Capital Partners's DexCom position peaked at $3.44M in Q3 2019.
  • 509 funds tracked by Wall St. Rank held DexCom as of Q4 2019.

Based on Silverleafe Capital Partners's 13F filing for Q4 2019, filed 2 Jan 2020.